Abstract
Due to its high stability and excellent performance, inorganic nanomaterials have attracted much attention in the research of disease diagnosis and treatment. Focusing on inorganic nanomaterials, high-temperature pyrolysis has been used to successfully prepare Fe₃O₄ nanoparticles with different particle sizes. The diagnosis and treatment of Alzheimer's disease have advanced, and many new diagnostic methods have been adopted clinically. In this paper, Fe₃O₄ nanoparticle magnetic resonance imaging technology is used to explore the application of magnetic Fe₃O₄ inorganic nanomaterials in cerebrovascular diseases in vivo. The results show that SWI has higher sensitivity and semi-quantitative advantages than traditional T2WI imaging technology. With different critical SWI concentrations, this article lays the experimental foundation for the clinical progress of inorganic nanomaterials and plays an important role in the treatment of cerebrovascular diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
